EP 06: The Most Effective Treatment for Obesity

The Better Prescription

Sometimes, despite eating well and exercising, we still struggle with our weight, which can often lead to other complications like diabetes, heart disease, and strokes. Today, on The Better Prescription, Dr. Minni Malhotra discusses the latest research on the complexity of obesity. She explains the recent studies on nicotinamide mononucleotide and nicotinamide adenine dinucleotide and their effects on glucose uptake. She also discusses the brain’s own “happy hormone” serotonin, how it’s related to FLP-7, and how this could hold the secret to better health. Tune in today to hear why diet supplements may not be the best choice to achieve weight loss, but the solution you may be looking for may already be in your own mind!

Key Points From This Episode:

• An introduction to today’s case study: a female client in her 40s, struggling to get her weight under control.
• Dr. Malhotra introduces the latest clinical trial of postmenopausal women with pre diabetes.
• What nicotinamide mononucleotide (NMN) is and how it increases glucose uptake in the skeletal muscles.
• How a study with mice led several companies to market NMN as a dietary supplement.
• What nicotinamide adenine dinucleotide (NAD) is and how it could be useful to weight loss.
• The necessity of more studies to determine if NMN has beneficial effects on the management of pre-diabetes and diabetes.
• Why diet supplements may not be the best choice to help you achieve weight loss.
• Another study reveals that serotonin, the “happy hormone,” has the potential to spur fat loss.
• What FLP-7 is and how it is stimulated in the brain.
• The importance of happy hormones, stress management, and lifestyle on weight loss.
• How Dr. Malhotra practice helps patients address obesity by creating a blueprint that factors in not only nutrition and exercise, but also mind mastery.

Links Mentioned in Today’s Episode:

Anchor Wellness Center

Minni Malhotra

The Institute for Functional Medicine